金陵药业：分公司金陵制药厂获得《药物临床试验批准通知书》

Group 1 - The company, Jinling Pharmaceutical, announced on September 3 that its subsidiary, Nanjing Jinling Pharmaceutical Factory, received a clinical trial application acceptance notice for Olaragol tablets from the National Medical Products Administration [1] - The company has also received the approval notice for the clinical trial, allowing the commencement of Phase III clinical research for Olaragol tablets [1]